Cargando…
Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis
An interleukin 4 (IL-4)-specific monoclonal antibody (mAb) was administered to mice infected systemically with the yeast Candida albicans, and the animals were monitored for mortality, development of delayed-type hypersensitivity, production of antibodies of different isotypes, release of IL-2, IL-4...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2119284/ https://www.ncbi.nlm.nih.gov/pubmed/1535368 |
Ejemplares similares
-
Oxazolone Colitis: A Murine Model of T Helper Cell Type 2 Colitis Treatable with Antibodies to Interleukin 4
por: Boirivant, Monica, et al.
Publicado: (1998) -
Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis
por: Li, Mengmeng, et al.
Publicado: (2020) -
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response
Publicado: (1993) -
Impaired Interleukin 4 Signaling in T Helper Type 1 Cells
por: Huang, Hua, et al.
Publicado: (1998) -
Endogenous Interleukin 4 Is Required for Development of Protective CD4(+) T Helper Type 1 Cell Responses to Candida albicans
por: Mencacci, Antonella, et al.
Publicado: (1998)